331 related articles for article (PubMed ID: 24401606)
1. Heme oxygenase-1 mediates oxidative stress and apoptosis in coxsackievirus B3-induced myocarditis.
Ursu ON; Sauter M; Ettischer N; Kandolf R; Klingel K
Cell Physiol Biochem; 2014; 33(1):52-66. PubMed ID: 24401606
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotection of H2S by downregulating iNOS and upregulating HO-1 expression in mice with CVB3-induced myocarditis.
Hua W; Chen Q; Gong F; Xie C; Zhou S; Gao L
Life Sci; 2013 Dec; 93(24):949-54. PubMed ID: 24140888
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis.
Cai Z; Shen L; Ma H; Yang J; Yang D; Chen H; Wei J; Lu Q; Wang DW; Xiang M; Wang J
Circ Heart Fail; 2015 Jul; 8(4):809-18. PubMed ID: 25985795
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of 12/15-LO ameliorates CVB3-induced myocarditis by activating Nrf2.
Ai F; Zheng J; Zhang Y; Fan T
Chem Biol Interact; 2017 Jun; 272():65-71. PubMed ID: 28506553
[TBL] [Abstract][Full Text] [Related]
7. Expression of inducible nitric oxide synthase in experimental viral myocarditis.
Glück B; Merkle I; Dornberger G; Stelzner A
Herz; 2000 May; 25(3):255-60. PubMed ID: 10904848
[TBL] [Abstract][Full Text] [Related]
8. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.
Li K; Xu W; Guo Q; Jiang Z; Wang P; Yue Y; Xiong S
Circ Res; 2009 Aug; 105(4):353-64. PubMed ID: 19608981
[TBL] [Abstract][Full Text] [Related]
9. Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication.
Qiu Y; Ye X; Zhang HM; Hanson P; Zhao G; Tong L; Xie R; Yang D
PLoS Pathog; 2017 Dec; 13(12):e1006744. PubMed ID: 29220410
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of iNOS protects cardiomyocytes against coxsackievirus B3-induced cell injury by suppressing autophagy.
Qi L; Xin Q; Wenjun J
Biomed Pharmacother; 2017 Jul; 91():673-679. PubMed ID: 28499238
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
[TBL] [Abstract][Full Text] [Related]
12. Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication.
Lindner D; Li J; Savvatis K; Klingel K; Blankenberg S; Tschöpe C; Westermann D
Mediators Inflamm; 2014; 2014():519528. PubMed ID: 25374444
[TBL] [Abstract][Full Text] [Related]
13. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma.
Zhang Y; Zhu H; Huang C; Cui X; Gao Y; Huang Y; Gong W; Zhao Y; Guo S
J Cardiovasc Pharmacol; 2006 Feb; 47(2):190-5. PubMed ID: 16495755
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV reduces cardiomyocyte apoptosis in a murine model of coxsackievirus B3-induced viral myocarditis.
Liu T; Yang F; Liu J; Zhang M; Sun J; Xiao Y; Xiao Z; Niu H; Ma R; Wang Y; Liu X; Dong Y
Exp Anim; 2019 Nov; 68(4):549-558. PubMed ID: 31243190
[TBL] [Abstract][Full Text] [Related]
17. Induction of myocardial nitric oxide synthase by Coxsackie B3 virus in mice.
Robinson NM; Zhang HY; Bevan AL; De Belder AJ; Moncada S; Martin JF; Archard LC
Eur J Clin Invest; 1999 Aug; 29(8):700-7. PubMed ID: 10457155
[TBL] [Abstract][Full Text] [Related]
18. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
19. Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders.
Szalay G; Sauter M; Hald J; Weinzierl A; Kandolf R; Klingel K
Am J Pathol; 2006 Dec; 169(6):2085-93. PubMed ID: 17148671
[TBL] [Abstract][Full Text] [Related]
20. Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis.
Opavsky MA; Martino T; Rabinovitch M; Penninger J; Richardson C; Petric M; Trinidad C; Butcher L; Chan J; Liu PP
J Clin Invest; 2002 Jun; 109(12):1561-9. PubMed ID: 12070303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]